MonoSol Rx, Strativa extend strategic relationship
WARREN, N.J. A subsidiary of a generic drug maker has entered into a new licensing and development agreement that grants the option to develop three new products for a drug delivery company.
Strativa has the option to license exclusive U.S. commercialization rights for the three additional oral soluble film products to be developed using MonoSol Rx’s PharmFilm technology, the companies said in a joint statement.
The new option agreements are an extension of the strategic relationship between MonoSol Rx and Strativa, initiated in June 2008 when Strativa acquired exclusive U.S. commercialization rights to MonoSol Rx’s ondansetron OSF, which will be marketed under the trade name Zuplenz. The new drug application for Zuplenz was accepted for review by the Food and Drug Administration in June 2009, and a response is expected in the first quarter 2010 as mandated by the Prescription Drug User Fee Act guidelines.
Walgreens offering H1N1 vaccinations at all pharmacies, Take Care Clinics nationwide
DEERFIELD, Ill. The once-scarce H1N1 vaccine now is available daily at all of the more than 7,100 Walgreens pharmacies and 350 Take Care Clinics throughout the country, Walgreens announced Monday.
With nearly all states lifting priority group vaccination restrictions, Walgreens is able to offer H1N1 vaccine to anyone in those states who wants a vaccination and who meets state age requirements. Priority group vaccination restrictions are still in effect in Hawaii only.
H1N1 vaccinations are available at Walgreens pharmacies on a walk-in basis when an immunizing pharmacist is on staff and also may be available by appointment. Additionally, Take Care Clinics at select Walgreens stores in 19 states have board-certified nurse practitioners and physician assistants who will provide vaccinations on a walk-in basis daily, pending vaccine availability. Age restrictions for pharmacist-administered vaccinations vary by state, while Take Care Clinics can immunize children ages 2 years and above.
“We share with government and health officials nationwide the goal of protecting as many people as possible from the H1N1 virus, while also helping to lessen the impact or prevent a third wave of H1N1 activity,” said Walgreens president and CEO Greg Wasson. “Soon, anyone in the country who wants an H1N1 vaccination will be able to get one. And by offering convenient, affordable access to the vaccine, as well as other health and wellness resources, Walgreens continues to play an integral role in helping people stay well throughout the flu season.”
The cost for the administration of H1N1 vaccine at Walgreens and Take Care Clinics is $18. Vaccinations are covered by Medicare and may be covered by Medicaid and other insurance plans. Consumers are encouraged to check with their insurance provider for coverage details.
For the nearest Walgreens pharmacy, consumers can call 1-800-Walgreens or visit www.walgreens.com/flu. For Take Care Clinic locations, consumers should visit www.takecarehealth.com or call 1-866-Take-Care.
Teva announces availability of Parkinson’s disease generic
NORTH WALES, Pa. A generic drug maker has announced the availability of a treatment of the signs and symptoms of idiopathic Parkinson’s disease.
Pramipexole diHCl tablets are available in a 0.125-mg strength, in a bottle size of 63; and in 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths in bottle sizes of 90. The generic is equivalent to Mirapex, which was developed by Boehringer Ingelheim Pharmaceuticals.
“Our customers count on Teva for a continuous supply of new generic products,” said Maureen Cavanaugh, VP customer operations and marketing. “With the launch of pramipexole dihydrochloride tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”